{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:18:59Z","timestamp":1794608339985,"version":"4.9.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011717","name":"Leuka","doi-asserted-by":"publisher","award":["2022\/FuF\/001"],"award-info":[{"award-number":["2022\/FuF\/001"]}],"id":[{"id":"10.13039\/100011717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["SEBCATP-2022\/100009"],"award-info":[{"award-number":["SEBCATP-2022\/100009"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["306752\/Z\/23\/Z"],"award-info":[{"award-number":["306752\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["306752\/Z\/23\/Z"],"award-info":[{"award-number":["306752\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["306752\/Z\/23\/Z"],"award-info":[{"award-number":["306752\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["306752\/Z\/23\/Z"],"award-info":[{"award-number":["306752\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["306752\/Z\/23\/Z"],"award-info":[{"award-number":["306752\/Z\/23\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>N-acetyltransferase 10 (NAT10) is a multifunctional enzyme that harbors RNA acetyltransferase and RNA helicase domains and has emerged as a therapeutic vulnerability in solid and hematological malignancies. By coupling Proteolysis Targeting Chimera-mediated degradation of NAT10 with a deep mutational scanning assay, followed by validations in biochemical assays, human cell lines, and female mouse xenografts, we find that the RNA helicase domain of NAT10 enhances cancer cell proliferation and tumor growth. This proliferative function of NAT10 is independent of RNA acetylation but requires its RNA-binding activity. The RNA helicase domain of NAT10 is required for 18S rRNA binding, promoting biogenesis of the 40S ribosomal subunit, while simultaneously interfering with the deposition of the conserved 18S rRNA modification m\u00b9acp\u00b3\u03a8. Loss of m\u00b9acp\u00b3\u03a8 in 18S rRNA enhances cancer cell proliferation, revealing that NAT10 promotes the biogenesis of hypomodified ribosomes to facilitate tumor growth. These findings uncover a mechanism by which NAT10 promotes cancer cell proliferation and establish its RNA helicase domain as a potential therapeutic target.<\/jats:p>","DOI":"10.1038\/s41467-026-76383-w","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T02:11:40Z","timestamp":1786155100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation"],"prefix":"10.1038","volume":"17","author":[{"given":"Mahmood H.","family":"Dalhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharath","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1842-5838","authenticated-orcid":false,"given":"Maria","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Serio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khulood A.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3422-2313","authenticated-orcid":false,"given":"Adam","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5159-7175","authenticated-orcid":false,"given":"Ajay","family":"Edakkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Raikundalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Landmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Asby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Stamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3202-9935","authenticated-orcid":false,"given":"Judith","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-7560","authenticated-orcid":false,"given":"Yogeshkumar","family":"Malam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios","family":"Aspris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmely A.","family":"Patrasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7564-5423","authenticated-orcid":false,"given":"Stephanie","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-6592","authenticated-orcid":false,"given":"George","family":"Giotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9068-5776","authenticated-orcid":false,"given":"Walid T.","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-161X","authenticated-orcid":false,"given":"Brian J. P.","family":"Huntly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-7586","authenticated-orcid":false,"given":"Fotios","family":"Sampaziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4865-7648","authenticated-orcid":false,"given":"Konstantinos","family":"Tzelepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-830X","authenticated-orcid":false,"given":"Daniel","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"76383_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nature14427","volume":"520","author":"H Khatter","year":"2015","unstructured":"Khatter, H., Myasnikov, A. G., Natchiar, S. K. & Klaholz, B. P. Structure of the human 80S ribosome. Nature 520, 640\u2013645 (2015).","journal-title":"Nature"},{"key":"76383_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41576-018-0008-z","volume":"19","author":"NR Genuth","year":"2018","unstructured":"Genuth, N. R. & Barna, M. Heterogeneity and specialized functions of translation machinery: from genes to organisms. Nat. Rev. Genet 19, 431\u2013452 (2018).","journal-title":"Nat. Rev. Genet"},{"key":"76383_CR3","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.tcb.2024.10.001","volume":"35","author":"I Milenkovic","year":"2025","unstructured":"Milenkovic, I. & Novoa, E. M. Dynamic rRNA modifications as a source of ribosome heterogeneity. Trends Cell Biol. 35, 604\u2013614 (2025).","journal-title":"Trends Cell Biol."},{"key":"76383_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107611","volume":"31","author":"A Babaian","year":"2020","unstructured":"Babaian, A. et al. Loss of m\u00b9acp\u00b3\u03a8 ribosomal RNA modification is a major feature of cancer. Cell Rep. 31, 107611 (2020).","journal-title":"Cell Rep."},{"key":"76383_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1261\/rna.078994.121","volume":"28","author":"H Huang","year":"2022","unstructured":"Huang, H., Parker, M. & Karbstein, K. The modifying enzyme Tsr3 establishes the hierarchy of Rio kinase binding in 40S ribosome assembly. RNA 28, 568\u2013582 (2022).","journal-title":"RNA"},{"key":"76383_CR6","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1093\/nar\/gkw244","volume":"44","author":"B Meyer","year":"2016","unstructured":"Meyer, B. et al. Ribosome biogenesis factor Tsr3 is the aminocarboxypropyl transferase responsible for 18S rRNA hypermodification in yeast and humans. Nucleic Acids Res. 44, 4304\u20134316 (2016).","journal-title":"Nucleic Acids Res"},{"key":"76383_CR7","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1016\/j.cell.2024.06.019","volume":"187","author":"Y Cheng","year":"2024","unstructured":"Cheng, Y. et al. A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence. Cell 187, 4770\u20134789.e4723 (2024).","journal-title":"Cell"},{"key":"76383_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41388-024-02975-9","volume":"43","author":"MH Dalhat","year":"2024","unstructured":"Dalhat, M. H., Narayan, S., Serio, H. & Arango, D. Dissecting the oncogenic properties of essential RNA-modifying enzymes: a focus on NAT10. Oncogene 43, 1077\u20131086 (2024).","journal-title":"Oncogene"},{"key":"76383_CR9","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.yexcr.2009.03.007","volume":"315","author":"Q Shen","year":"2009","unstructured":"Shen, Q. et al. NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp. Cell Res. 315, 1653\u20131667 (2009).","journal-title":"Exp. Cell Res"},{"key":"76383_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.bbrc.2018.04.047","volume":"499","author":"Y Tan","year":"2018","unstructured":"Tan, Y. et al. Loss of nucleolar localization of NAT10 promotes cell migration and invasion in hepatocellular carcinoma. Biochem Biophys. Res. Commun. 499, 1032\u20131038 (2018).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"76383_CR11","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1158\/0008-5472.CAN-17-2281","volume":"77","author":"BR Tschida","year":"2017","unstructured":"Tschida, B. R. et al. Sleeping beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumors. Cancer Res. 77, 6576\u20136588 (2017).","journal-title":"Cancer Res"},{"key":"76383_CR12","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41556-024-01548-y","volume":"26","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. NAT10-mediated mRNA N(4)-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia. Nat. Cell Biol. 26, 2168\u20132182 (2024).","journal-title":"Nat. Cell Biol."},{"key":"76383_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41422-023-00793-4","volume":"33","author":"L Liao","year":"2023","unstructured":"Liao, L. et al. Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Res. 33, 355\u2013371 (2023).","journal-title":"Cell Res"},{"key":"76383_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","volume":"6","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1. Signal Transduct. Target Ther. 6, 173 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"76383_CR15","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie, R. et al. NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res. 83, 1666\u20131683 (2023).","journal-title":"Cancer Res"},{"key":"76383_CR16","doi-asserted-by":"publisher","first-page":"4526","DOI":"10.1016\/j.molcel.2025.11.010","volume":"85","author":"R Amin","year":"2025","unstructured":"Amin, R. et al. NAT10 promotes cancer metastasis by modulating p300\/CBP activity through chromatin-associated tRNA. Mol. Cell 85, 4526\u20134544.e4518 (2025).","journal-title":"Mol. Cell"},{"key":"76383_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13046-025-03362-2","volume":"44","author":"L Huang","year":"2025","unstructured":"Huang, L. et al. N(4)-acetylcytidine modification of ITGB5 mRNA mediated by NAT10 promotes perineural invasion in pancreatic ductal adenocarcinoma. J. Exp. Clin. Cancer Res. 44, 103 (2025).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"76383_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads6021","volume":"11","author":"JF Chen","year":"2025","unstructured":"Chen, J. F. et al. An in vivo screen identifies NAT10 as a master regulator of brain metastasis. Sci. Adv. 11, eads6021 (2025).","journal-title":"Sci. Adv."},{"key":"76383_CR19","doi-asserted-by":"publisher","first-page":"35724","DOI":"10.1074\/jbc.C114.602698","volume":"289","author":"S Ito","year":"2014","unstructured":"Ito, S. et al. Human NAT10 is an ATP-dependent RNA acetyltransferase responsible for N4-acetylcytidine formation in 18 S ribosomal RNA (rRNA). J. Biol. Chem. 289, 35724\u201335730 (2014).","journal-title":"J. Biol. Chem."},{"key":"76383_CR20","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/nar\/gkv075","volume":"43","author":"S Sharma","year":"2015","unstructured":"Sharma, S. et al. Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1\/THUMPD1. Nucleic Acids Res. 43, 2242\u20132258 (2015).","journal-title":"Nucleic Acids Res"},{"key":"76383_CR21","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"D Arango","year":"2018","unstructured":"Arango, D. et al. Acetylation of cytidine in mRNA promotes translation efficiency. Cell 175, 1872\u20131886.e1824 (2018).","journal-title":"Cell"},{"key":"76383_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13046-022-02586-w","volume":"42","author":"M Deng","year":"2023","unstructured":"Deng, M. et al. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. J. Exp. Clin. Cancer Res. 42, 9 (2023).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"76383_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang, G. et al. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin. Transl. Med. 12, e738 (2022).","journal-title":"Clin. Transl. Med"},{"key":"76383_CR24","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1038\/s41388-024-03185-z","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. m(6)A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation. Oncogene 43, 3498\u20133516 (2024).","journal-title":"Oncogene"},{"key":"76383_CR25","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/cac2.12595","volume":"44","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer Commun. (Lond.) 44, 1018\u20131041 (2024).","journal-title":"Cancer Commun. (Lond.)"},{"key":"76383_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1747","volume":"14","author":"M Ding","year":"2024","unstructured":"Ding, M. et al. N-acetyltransferase 10 facilitates tumorigenesis of diffuse large B-cell lymphoma by regulating AMPK\/mTOR signalling through N4-acetylcytidine modification of SLC30A9. Clin. Transl. Med. 14, e1747 (2024).","journal-title":"Clin. Transl. Med"},{"key":"76383_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112810","volume":"42","author":"W Wei","year":"2023","unstructured":"Wei, W. et al. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Rep. 42, 112810 (2023).","journal-title":"Cell Rep."},{"key":"76383_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112860","volume":"28","author":"H Li","year":"2025","unstructured":"Li, H. et al. Mechanistic study of N-acetyltransferase 10 deficiency enhancing olaparib sensitivity in triple negative breast cancer by inhibiting RAD51 N4-acetylcytidine modification. iScience 28, 112860 (2025).","journal-title":"iScience"},{"key":"76383_CR29","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.7150\/thno.104310","volume":"15","author":"Q Wang","year":"2025","unstructured":"Wang, Q. et al. Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis. Theranostics 15, 2428\u20132450 (2025).","journal-title":"Theranostics"},{"key":"76383_CR30","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1016\/j.molcel.2022.05.016","volume":"82","author":"D Arango","year":"2022","unstructured":"Arango, D. et al. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine. Mol. Cell 82, 2797\u20132814.e2711 (2022).","journal-title":"Mol. Cell"},{"key":"76383_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41586-020-2418-2","volume":"583","author":"A Sas-Chen","year":"2020","unstructured":"Sas-Chen, A. et al. Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping. Nature 583, 638\u2013643 (2020).","journal-title":"Nature"},{"key":"76383_CR32","doi-asserted-by":"publisher","first-page":"e1006804","DOI":"10.1371\/journal.pgen.1006804","volume":"13","author":"S Sharma","year":"2017","unstructured":"Sharma, S. et al. Specialized box C\/D snoRNPs act as antisense guides to target RNA base acetylation. PLoS Genet. 13, e1006804 (2017).","journal-title":"PLoS Genet"},{"key":"76383_CR33","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1093\/nar\/gkac404","volume":"50","author":"ML Bortolin-Cavaille","year":"2022","unstructured":"Bortolin-Cavaille, M. L. et al. Probing small ribosomal subunit RNA helix 45 acetylation across eukaryotic evolution. Nucleic Acids Res. 50, 6284\u20136299 (2022).","journal-title":"Nucleic Acids Res"},{"key":"76383_CR34","first-page":"1582","volume":"28","author":"S Thalalla Gamage","year":"2022","unstructured":"Thalalla Gamage, S. et al. Antisense pairing and SNORD13 structure guide RNA cytidine acetylation. RNA 28, 1582\u20131596 (2022).","journal-title":"RNA"},{"key":"76383_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads2923","volume":"11","author":"S Thalalla Gamage","year":"2025","unstructured":"Thalalla Gamage, S. et al. Transfer RNA acetylation regulates in vivo mammalian stress signaling. Sci. Adv. 11, eads2923 (2025).","journal-title":"Sci. Adv."},{"key":"76383_CR36","doi-asserted-by":"crossref","unstructured":"Hafner, J. et al. Sni445 recruits box C\/D snoRNPs snR4 and snR45 to guide ribosomal RNA acetylation by Kre33. Nucleic Acids Res. 54, gkag030 (2026).","DOI":"10.1093\/nar\/gkag030"},{"key":"76383_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1126\/science.1252651","volume":"344","author":"D Larrieu","year":"2014","unstructured":"Larrieu, D., Britton, S., Demir, M., Rodriguez, R. & Jackson, S. P. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science 344, 527\u2013532 (2014).","journal-title":"Science"},{"key":"76383_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112156","volume":"9","author":"M Taoka","year":"2014","unstructured":"Taoka, M. et al. RNA cytidine acetyltransferase of small-subunit ribosomal RNA: identification of acetylation sites and the responsible acetyltransferase in fission yeast, Schizosaccharomyces pombe. PLoS One 9, e112156 (2014).","journal-title":"PLoS One"},{"key":"76383_CR39","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41388-025-03661-0","volume":"45","author":"H Wang","year":"2026","unstructured":"Wang, H. et al. NAT10 triggers colorectal cancer progression via promoting PPAN-regulated DNA damage repair. Oncogene 45, 558\u2013576 (2026).","journal-title":"Oncogene"},{"key":"76383_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ady0301","volume":"12","author":"F Huang","year":"2026","unstructured":"Huang, F. et al. Nat10-mediated ac4C epitranscriptomics orchestrates hematopoietic stem\/progenitor cell fate determination via translation control. Sci. Adv. 12, eady0301 (2026).","journal-title":"Sci. Adv."},{"key":"76383_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehae707","volume":"46","author":"C Yu","year":"2025","unstructured":"Yu, C. et al. NAT10 promotes vascular remodelling via mRNA ac4C acetylation. Eur. Heart J. 46, 288\u2013304 (2025).","journal-title":"Eur. Heart J."},{"key":"76383_CR42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41418-025-01577-6","volume":"33","author":"L Shi","year":"2026","unstructured":"Shi, L. et al. NAT10 regulates heart development and function by maintaining the expression of genes related to fatty acid beta-oxidation and heart contraction. Cell Death Differ. 33, 358\u2013373 (2026).","journal-title":"Cell Death Differ."},{"key":"76383_CR43","doi-asserted-by":"crossref","unstructured":"Zhou, M. et al. Structure of the NAT10 acetyltransferase and mechanism of tRNA acetylation. Nat. Commun. 17, 7763 (2026).","DOI":"10.1038\/s41467-026-74222-6"},{"key":"76383_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3570-4","volume":"17","author":"Q Li","year":"2017","unstructured":"Li, Q. et al. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity. BMC Cancer 17, 605 (2017).","journal-title":"BMC Cancer"},{"key":"76383_CR45","first-page":"4215","volume":"8","author":"R Ma","year":"2016","unstructured":"Ma, R. et al. Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition. Am. J. Transl. Res. 8, 4215\u20134223 (2016).","journal-title":"Am. J. Transl. Res"},{"key":"76383_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-023-01355-8","volume":"9","author":"Z Pan","year":"2023","unstructured":"Pan, Z. et al. Role of NAT10-mediated ac4C-modified HSP90AA1 RNA acetylation in ER stress-mediated metastasis and lenvatinib resistance in hepatocellular carcinoma. Cell Death Discov. 9, 56 (2023).","journal-title":"Cell Death Discov."},{"key":"76383_CR47","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/nprot.2012.069","volume":"7","author":"R Hietpas","year":"2012","unstructured":"Hietpas, R., Roscoe, B., Jiang, L. & Bolon, D. N. Fitness analyses of all possible point mutations for regions of genes in yeast. Nat. Protoc. 7, 1382\u20131396 (2012).","journal-title":"Nat. Protoc."},{"key":"76383_CR48","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/emboj.2009.69","volume":"28","author":"S Chimnaronk","year":"2009","unstructured":"Chimnaronk, S. et al. RNA helicase module in an acetyltransferase that modifies a specific tRNA anticodon. EMBO J. 28, 1362\u20131373 (2009).","journal-title":"EMBO J."},{"key":"76383_CR49","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/emboj.2008.154","volume":"27","author":"Y Ikeuchi","year":"2008","unstructured":"Ikeuchi, Y., Kitahara, K. & Suzuki, T. The RNA acetyltransferase driven by ATP hydrolysis synthesizes N4-acetylcytidine of tRNA anticodon. EMBO J. 27, 2194\u20132203 (2008).","journal-title":"EMBO J."},{"key":"76383_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccr.2007.08.031","volume":"12","author":"BH Lee","year":"2007","unstructured":"Lee, B. H. et al. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 12, 367\u2013380 (2007).","journal-title":"Cancer Cell"},{"key":"76383_CR51","first-page":"938","volume":"30","author":"S Relier","year":"2024","unstructured":"Relier, S., Schiffers, S., Beiki, H. & Oberdoerffer, S. Enhanced ac4C detection in RNA via chemical reduction and cDNA synthesis with modified dNTPs. RNA 30, 938\u2013953 (2024).","journal-title":"RNA"},{"key":"76383_CR52","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.molcel.2024.03.018","volume":"84","author":"H Beiki","year":"2024","unstructured":"Beiki, H. et al. Detection of ac4C in human mRNA is preserved upon data reassessment. Mol. Cell 84, 1611\u20131625.e1613 (2024).","journal-title":"Mol. Cell"},{"key":"76383_CR53","doi-asserted-by":"publisher","first-page":"e112699","DOI":"10.15252\/embj.2022112699","volume":"42","author":"K Dorner","year":"2023","unstructured":"Dorner, K., Ruggeri, C., Zemp, I. & Kutay, U. Ribosome biogenesis factors-from names to functions. EMBO J. 42, e112699 (2023).","journal-title":"EMBO J."},{"key":"76383_CR54","doi-asserted-by":"publisher","first-page":"eabj5338","DOI":"10.1126\/science.abj5338","volume":"373","author":"S Singh","year":"2021","unstructured":"Singh, S., Vanden Broeck, A., Miller, L., Chaker-Margot, M. & Klinge, S. Nucleolar maturation of the human small subunit processome. Science 373, eabj5338 (2021).","journal-title":"Science"},{"key":"76383_CR55","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nsmb.3476","volume":"24","author":"J Cheng","year":"2017","unstructured":"Cheng, J., Kellner, N., Berninghausen, O., Hurt, E. & Beckmann, R. 3.2-A-resolution structure of the 90S preribosome before A1 pre-rRNA cleavage. Nat. Struct. Mol. Biol. 24, 954\u2013964 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"76383_CR56","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cell.2016.06.014","volume":"166","author":"M Kornprobst","year":"2016","unstructured":"Kornprobst, M. et al. Architecture of the 90S Pre-ribosome: A Structural View on the Birth of the Eukaryotic Ribosome. Cell 166, 380\u2013393 (2016).","journal-title":"Cell"},{"key":"76383_CR57","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.molcel.2019.06.032","volume":"75","author":"J Cheng","year":"2019","unstructured":"Cheng, J. et al. Thermophile 90S Pre-ribosome structures reveal the reverse order of co-transcriptional 18S rRNA subdomain integration. Mol. Cell 75, 1256\u20131269.e1257 (2019).","journal-title":"Mol. Cell"},{"key":"76383_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54368-x","volume":"15","author":"A Delgado-Tejedor","year":"2024","unstructured":"Delgado-Tejedor, A. et al. Native RNA nanopore sequencing reveals antibiotic-induced loss of rRNA modifications in the A- and P-sites. Nat. Commun. 15, 10054 (2024).","journal-title":"Nat. Commun."},{"key":"76383_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11307","volume":"7","author":"I Sovic","year":"2016","unstructured":"Sovic, I. et al. Fast and sensitive mapping of nanopore sequencing reads with GraphMap. Nat. Commun. 7, 11307 (2016).","journal-title":"Nat. Commun."},{"key":"76383_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqae052","volume":"6","author":"Z Guo","year":"2024","unstructured":"Guo, Z. et al. Nanopore current events magnifier (nanoCEM): a novel tool for visualizing current events at modification sites of nanopore sequencing. NAR Genom. Bioinform 6, lqae052 (2024).","journal-title":"NAR Genom. Bioinform"},{"key":"76383_CR61","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nmeth.3290","volume":"12","author":"M Jain","year":"2015","unstructured":"Jain, M. et al. Improved data analysis for the MinION nanopore sequencer. Nat. Methods 12, 351\u2013356 (2015).","journal-title":"Nat. Methods"},{"key":"76383_CR62","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/nar\/gkq931","volume":"39","author":"B Meyer","year":"2011","unstructured":"Meyer, B. et al. The Bowen\u2013Conradi syndrome protein Nep1 (Emg1) has a dual role in eukaryotic ribosome biogenesis, as an essential assembly factor and in the methylation of Psi1191 in yeast 18S rRNA. Nucleic Acids Res. 39, 1526\u20131537 (2011).","journal-title":"Nucleic Acids Res"},{"key":"76383_CR63","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1093\/nar\/gkq1131","volume":"39","author":"SR Thomas","year":"2011","unstructured":"Thomas, S. R., Keller, C. A., Szyk, A., Cannon, J. R. & Laronde-Leblanc, N. A. Structural insight into the functional mechanism of Nep1\/Emg1 N1-specific pseudouridine methyltransferase in ribosome biogenesis. Nucleic Acids Res. 39, 2445\u20132457 (2011).","journal-title":"Nucleic Acids Res"},{"key":"76383_CR64","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1093\/nar\/gkp1189","volume":"38","author":"JP Wurm","year":"2010","unstructured":"Wurm, J. P. et al. The ribosome assembly factor Nep1 responsible for Bowen\u2013Conradi syndrome is a pseudouridine-N1-specific methyltransferase. Nucleic Acids Res. 38, 2387\u20132398 (2010).","journal-title":"Nucleic Acids Res"},{"key":"76383_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01869-3","volume":"22","author":"K Su","year":"2024","unstructured":"Su, K. et al. NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21. Cell Commun. Signal 22, 490 (2024).","journal-title":"Cell Commun. Signal"},{"key":"76383_CR66","doi-asserted-by":"publisher","first-page":"zcae017","DOI":"10.1093\/narcan\/zcae017","volume":"6","author":"SP Hwang","year":"2024","unstructured":"Hwang, S. P. & Denicourt, C. The impact of ribosome biogenesis in cancer: from proliferation to metastasis. NAR Cancer 6, zcae017 (2024).","journal-title":"NAR Cancer"},{"key":"76383_CR67","doi-asserted-by":"crossref","unstructured":"Sleiman, S. & Dragon, F. Recent advances on the structure and function of RNA acetyltransferase Kre33\/NAT10. Cells 8, 1035 (2019).","DOI":"10.3390\/cells8091035"},{"key":"76383_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03770-3","volume":"9","author":"G Balmus","year":"2018","unstructured":"Balmus, G. et al. Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome. Nat. Commun. 9, 1700 (2018).","journal-title":"Nat. Commun."},{"key":"76383_CR69","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1021\/acs.jmedchem.4c01909","volume":"68","author":"L Selvaratnam","year":"2025","unstructured":"Selvaratnam, L., Willson, T. M. & Schapira, M. Structural chemistry of helicase inhibition. J. Med. Chem. 68, 4022\u20134039 (2025).","journal-title":"J. Med. Chem."},{"key":"76383_CR70","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"76383_CR71","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"key":"76383_CR72","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"76383_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"76383_CR74","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1038\/s41596-019-0168-0","volume":"14","author":"OC Tysoe","year":"2019","unstructured":"Tysoe, O. C. et al. Isolation and propagation of primary human cholangiocyte organoids for the generation of bioengineered biliary tissue. Nat. Protoc. 14, 1884\u20131925 (2019).","journal-title":"Nat. Protoc."},{"key":"76383_CR75","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.aaz6964","volume":"371","author":"F Sampaziotis","year":"2021","unstructured":"Sampaziotis, F. et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science 371, 839\u2013846 (2021).","journal-title":"Science"},{"key":"76383_CR76","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41596-022-00680-z","volume":"17","author":"SM Blue","year":"2022","unstructured":"Blue, S. M. et al. Transcriptome-wide identification of RNA-binding protein binding sites using seCLIP-seq. Nat. Protoc. 17, 1223\u20131265 (2022).","journal-title":"Nat. Protoc."},{"key":"76383_CR77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"76383_CR78","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 27, 491\u2013499 (2017).","journal-title":"Genome Res."},{"key":"76383_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"76383_CR80","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"76383_CR81","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ramirez","year":"2016","unstructured":"Ramirez, F. et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 44, W160\u2013W165 (2016).","journal-title":"Nucleic Acids Res"},{"key":"76383_CR82","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"76383_CR83","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41586-020-2929-x","volume":"587","author":"M Ameismeier","year":"2020","unstructured":"Ameismeier, M. et al. Structural basis for the final steps of human 40S ribosome maturation. Nature 587, 683\u2013687 (2020).","journal-title":"Nature"},{"key":"76383_CR84","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","volume":"81","author":"EA Orellana","year":"2021","unstructured":"Orellana, E. A. et al. METTL1-mediated m(7)G modification of Arg-TCT tRNA drives oncogenic transformation. Mol. Cell 81, 3323\u20133338.e3314 (2021).","journal-title":"Mol. Cell"},{"key":"76383_CR85","doi-asserted-by":"publisher","unstructured":"Serio, H., Dalhat, M. H. & Arango, D. Nanopore Direct RNA sequencing. The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation. Zenodo https:\/\/doi.org\/10.5281\/zenodo.20799580 (2026).","DOI":"10.5281\/zenodo.20799580"},{"key":"76383_CR86","doi-asserted-by":"publisher","unstructured":"Dalhat, M. H., Serio, H. & Arango, D. DMS-Nseq. The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation. Zenodo https:\/\/doi.org\/10.5281\/zenodo.20784953 (2026).","DOI":"10.5281\/zenodo.20784953"},{"key":"76383_CR87","doi-asserted-by":"publisher","unstructured":"Serio, H., Narayan, S., Dalhat, M. H. & Arango, D. eCLIP-seq. The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation. Zenodo https:\/\/doi.org\/10.5281\/zenodo.20799456 (2026).","DOI":"10.5281\/zenodo.20799456"},{"key":"76383_CR88","doi-asserted-by":"publisher","unstructured":"Dalhat, M. H. & Arango, D. MErR-seq. The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation. Zenodo https:\/\/doi.org\/10.5281\/zenodo.21026515 (2026).","DOI":"10.5281\/zenodo.21026515"},{"key":"76383_CR89","doi-asserted-by":"publisher","unstructured":"Serio, H., Dalhat, M. H. & Arango, D. ac4C mapping. The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation. Zenodo https:\/\/doi.org\/10.5281\/zenodo.20801474 (2026).","DOI":"10.5281\/zenodo.20801474"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76383-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76383-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76383-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:02:59Z","timestamp":1788739379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76383-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76383"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76383-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.T. has received stock options, consultancy fees and research funding from Storm Therapeutics Ltd., Cambridge, UK. K.T. is stockholder of TEP Therapeutics Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9529"}}